Application Detail
Description of Medical Service
Autologous Chondrocyte Implantation aims to stimulate new cartilage production by encouraging the growth of cartilage cells (chondrocytes), which are responsible for production and maintenance of cartilage tissue. Healthy articular cartilage is harvested from the knee joint and sent to a laboratory, where the chondrocytes are isolated from the cartilage and expanded in a test tube or dish. Approximately five weeks after biopsy collection, the cultured chondrocytes are seeded onto a collagen scaffold. The scaffold/chondrocyte implant is then fixed in place at the injury site.Description of Medical Condition
Symptomatic loss of joint cartilage of the knee. Symptoms include pain, swelling, joint stiffness and joint clicking or locking. Joint cartilage (also called hyaline cartilage) has no blood vessels and therefore has limited potential for self-repair. Therefore, if left untreated, cartilage injury often progresses to osteoarthritis in the affected joint.Reason for Application
New MBS itemMedical Service Type
Therapeutic technologyPrevious Application Number/s
Not ApplicableAssociated Documentation
Application Summary and PICO Set
Application Summary (PDF 400 KB)Application Summary (Word 30 KB)
PICO Set (PDF 1280 KB)
PICO Set (Word 546 KB)
Consultation Survey
Consultation Survey (PDF 653 KB)Consultation Survey (Word 32 KB)
PASC Consultation
PASC consultation closed 15 March 2024
MSAC Consultation
MSAC consultation TBA – please subscribe to the MSAC Email Bulletin to be notified when consultation opens for this application
For further information please refer to PASC, ESC, MSAC Key Dates
For further information on the consultation process please refer to MSAC Consultation Process
PICO Confirmation
PICO Confirmation (PDF 778 KB)PICO Confirmation (Word 337 KB)